Arian Lundberg

10PUBLICATIONS
94CO-AUTHORS
Innate immunityEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

|Jul 17, 2024
Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer.

Shuang G Zhao, Matthew Bootsma, Stanley Zhou

|Jul 11, 2024
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.

Raunak Shrestha, Lisa N Chesner, Meng Zhang

|Jun 13, 2024
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression.

Meng Zhang, Martin Sjöström, Xiekui Cui

|Jun 08, 2023
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.

Arian Lundberg, Meng Zhang, Rahul Aggarwal

|Oct 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer.

Eric Feng, Nicholas R Rydzewski, Meng Zhang

Pageof 2

Frequent Collaborators

7 joint publications

David A Quigley

7 joint publications

Martin Sjöström

6 joint publications

Felix Y Feng

6 joint publications

Meng Zhang